Clinical Trials Browser

Phase 4 × dalpiciclib × Breast × Clear all

NCT06613373 2024-09-25

An Exploratory Clinical Study of CDK4/6i Dalpiciclib Combined With AI Neoadjuvant Therapy for Stage II-III HR+/HER2- Breast Cancer

Phase 4 Not yet recruiting

Breast Neoplasms